Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
Pharmafocus.comNews Headlines Register for News Alert
News for April 2005
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Super surgeries become an election issue
Royal College of GPs criticise plans..(more)

 Government promotes generic switch from GSK's Lamictal
Ranbaxy settles out of court with DH..(more)

 MHRA failing patients, warns report
HSC makes recommendations..(more)

 Strattera sales fall back over continuing safety concerns
Lilly first quarter sales solid..(more)

 Woolley Pau wins Novo Nordisk insulin accounts
Enthusiasm wins through..(more)

 Bextra withdrawal dents Pfizer's sales juggernaut
Pfizer cuts 2005 profit forecast..(more)

 PCT mergers won't solve financial problems, warns report
NHS Alliance launches major reports..(more)

 US court rules in favour of Lilly's Zyprexa
IVAX to appeal..(more)

 Labour makes clinical trials law a manifesto pledge
ABPI awaits government's response..(more)

 Ogilvy reshuffle sweetens Healthworld
New agency wins pharma accounts..(more)

 Novartis signs respiratory deal with UK biotech companies
New COPD treatment developed..(more)

 Conservatives promise to scrap Strategic Health Authorities and A&E targets
Conservatives outline NHS policies..(more)

 Eloxatin and Campto gain new NICE approval
Both drugs cost-effective..(more)

 Japanese companies merge to form Astellas
Yamanouchi and Fujisawa merge..(more)

 New depression treatment relieves sleep problems in patients
Valdoxan proves benefits..(more)

 Bextra suspended from European and US markets
EMEA singles out MSD's Arcoxia ..(more)

 Serono hit by two late-stage failures
Rebif still the star ..(more)

 No salesforce purge in Pfizer's $4 billion cuts
Transition year for Pfizer ..(more)

 'Fundamental misconceptions' in MP's report, says industry
MHRA singled out..(more)

 New hepatitis B treatment approved in US
FDA fast-tracks BMS's Baraclude ..(more)

 Industry issues warning as UK investment falls
R&D investment a concern..(more)

 Takeda abandons phase III diabetes drug
Takeda faces pipeline problems..(more)

 Super surgeries spell big changes for patients and pharma
Not the end for family doctor..(more)

 Government fails to meet GP recruitment target
Part-timers cloud picture..(more)

 Stroke audit uncovers alarming variation in medication in UK
Specialist stroke care improving..(more)

 UK promotes greater industry efforts on AIDS drugs
New framework launched..(more)

 Industry heads speak out against new European hurdle
EMEA sets out Road Map..(more)

 New drug applications to keep rising, European regulator says
EMEA hopes for increased budget..(more)

 And finally - the NSF for Long Term Conditions
NSF last of its kind..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.